DXCM vs VSAT · P/E 63, rev $2.50B vs rev $4.64B
DexCom Inc (DXCM) versus ViaSat Inc (VSAT) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
ViaSat Inc (VSAT) is a communication equipment company listed on NASDAQ.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported VSAT revenue for 2026-03-31 was $4.64B. Net income was -$34.1M. Revenue was up 2.7% from 2025-03-31 to 2026-03-31. VSAT currently screens at market cap $8.82B.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. VSAT currently screens at market cap $8.82B.
Not investment advice. Open the DXCM and VSAT stock pages for the full models.
Not investment advice.